NOVEL THERAPEUTIC USE FOR TREATING LEUKAEMIA

• 收藏
• 分享

专利权人:

发明人:

부리, 베르나르,카젤라, 피에르

申请号：

KR1020097013456

公开号：

KR1014582330000B1

申请日:

2007.12.27

申请国别(地区):

KR

年份:

2014

代理人:

摘要：

Use of N-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6 dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)-urea (I) and its hydrates, salts or solvates, for the preparation of medicament to treat leukemia and myeloids leukemia, is claimed. ACTIVITY : Cytostatic. The anti-tumor activity of (I) was tested in severe combined immunodeficient mice CB-17. The result showed that (I) exhibited tumor mass reduction of 80%. MECHANISM OF ACTION : None given.본 발명은 백혈병, 특히 골수성 백혈병을 치료하기 위한 신규한 치료 용도에 관한 것이다.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/